|会社名||Harte Hanks Inc （HARTE-HANKS）|
|概要||ハート・ハンクス(Harte-Hanks Inc.)は地元・地方・国家・国際の消費者及び企業間の販売業者に、直販サービス及びショッパー広告業務を提供する世界的なダイレクトマーケティング会社。同社は国内外で事業を行う直接販売事業部門及びカリフォルニア州・フロリダ州の地元・地方市場で事業を展開するショッパー事業部門により構成される。Harte-Hanks Shoppersはショッパー出版物を所有・経営・提供する会社(発行部数と収入に基づく)。平成23年12月期決算期において、直接販売事業の収益とショッパー事業の収益はそれぞれ同社の総収益の72%と28％を占めた。 ハ―ト・ハンクスは、米国のマ―ケティング会社。ウェブサイトの開発、デザインなどの代理店・デジタルサ―ビス、デ―タベ―スマ―ケティングソリュ―ションのほか、デ―タクレンジング・名寄せツ―ルの「トリリアム」ソフトウェア、デジタル印刷や発送業務などのダイレクトメ―ルサ―ビス、さらに多言語対応のカスタマ―サ―ビスを提供する。 Harte-Hanks, Inc. engages in the provision of marketing solutions. It specializes in consulting, data analytics, creative services, digital and social media, marketing strategy, marketing technology, and other related services. It supports a range of customers in the field of technology, travel and leisure, entertainment, pharmaceuticals, automotive, finance, and retail. The company was founded in 1923 and is headquartered in San Antonio, TX.|
|本社所在地||9601 McAllister Freeway Suite 610 San Antonio TX 78216 USA|
|代表者氏名||Alfred V. Tobia|
|代表者役職名||Chairman of the Board|
|決算概要||BRIEF: For the fiscal year ended 31 December 2018 Harte Hanks Inc revenues decreased 26% to $284.6M. Net income applicable to common stockholders excluding extraordinary items totaled $14.9M vs. loss of $45.3M. Revenues reflect United States segment decrease of 26% to $243.3M Other Countries segment decrease of 22% to $41.3M. Net Income reflects Gain on sale increase from $0K to $31M (income) Advertising Expenses decrease of 15% to $34.2M (expense).|
'Fauci is not 100% right': Top HHS official pushes back on infectious disease expert's recommendations 2020/07/12 17:50:34 Washington Examiner
Adm. Brett Giroir pushed back on some of the public health recommendations made by his colleague on the White House Coronavirus Task Force, Dr. Anthony Fauci.
Top HHS official says 'simple' behavior changes would curb pandemic 2020/07/12 14:07:00 NBC News
Steps like closing bars and wearing masks could have the same impact as widespread economic shutdowns, Admiral Brett Giroir said Sunday.
Trump sidelines public health advisers in growing rift over coronavirus response 2020/07/09 21:33:00 The Washington Post
Email from HHS adviser accusing CDC of ‘undermining President’ offers window into pressure on nation’s public health agency.
Trump's hydroxychloroquine obsession cost taxpayers at least $88 million 2020/07/08 15:48:29 Business Insider
President Trump repeatedly hyped an obscure antimalarial drug, hydroxychloroquine, as a potential miracle cure for COVID-19. But there was almost no solid scientific evidence to back that claim, and researchers quickly established that it had no effect on the disease. Despite its unlikely profile as a cure, hydroxychloroquine has received more federal research funding than any other single potential treatment, an Insider investigation has found. Taxpayers have devoted at least $88 million — and likely much more — on research and prescriptions for the drug. "It's been a disaster," Arthur Caplan, the founder of New York University School of Medicine's division of medical ethics, said. "There's too much money … chasing around that drug based on very weak evidence in the literature and a presidential endorsement." Visit Business Insider's homepage for more stories . Most Americans had never heard of hydroxychloroquine — the obscure antimalarial drug discovered in 1945 — until March 19. That's when President Donald Trump, speaking at a Coronavirus Task Force press conference in the White House briefing room with the blustering confidence of an old-time snake-oil salesman, first touted it as a likely miracle cure to defeat COVID-19.
Department of Health and Human Services to open 'surge' COVID-19 testing in Florida, Texas, Louisiana 2020/07/07 19:08:06 Channel NewsAsia
The U.S. Department of Health and Human Services (HHS) said on Tuesday there would be temporary free COVID-19 testing in three cities in Florida, Louisiana and Texas as the U.S. states tackle surging cases and hospitalizations.